Published in Br J Pharmacol on November 01, 2012
Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels. FEBS Open Bio (2015) 0.88
Coenzyme q10 therapy. Mol Syndromol (2014) 0.87
Mitochondrial Myopathy in Follow-up of a Patient With Chronic Fatigue Syndrome. J Investig Med High Impact Case Rep (2015) 0.81
CT and MRI imaging of the brain in MELAS syndrome. Pol J Radiol (2013) 0.79
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Life with 6000 genes. Science (1996) 41.51
Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1998) 10.74
Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science (1989) 9.71
Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys (2007) 8.24
A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature (1990) 7.89
Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta (1994) 4.93
ROS, mitochondria and the regulation of autophagy. Trends Cell Biol (2007) 3.73
Antioxidants in human health and disease. Annu Rev Nutr (1996) 3.44
Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci (2010) 3.32
Analysis and manipulation of yeast mitochondrial genes. Methods Enzymol (1991) 3.20
Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol Cell Biol (1992) 2.83
MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci U S A (1992) 2.82
A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet (2005) 2.73
Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta (1995) 2.71
Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci (2008) 2.39
The complete set of predicted genes from Saccharomyces cerevisiae in a readily usable form. Genome Res (1997) 2.31
A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun (1990) 2.21
Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med (2008) 1.63
Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach. Clin Chem (2004) 1.62
Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc Natl Acad Sci U S A (2004) 1.47
Mitochondrial disorders. Curr Opin Neurol (2007) 1.40
Mitochondrial tRNA 3' end metabolism and human disease. Nucleic Acids Res (2004) 1.37
Human coenzyme Q10 deficiency. Neurochem Res (2006) 1.34
Treatment for mitochondrial disorders. Cochrane Database Syst Rev (2006) 1.31
Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade. Mol Genet Metab (2009) 1.28
Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem J (1996) 1.24
Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand (2007) 1.24
MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Ann N Y Acad Sci (2010) 1.22
The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options. CNS Drugs (2006) 1.19
Approaches to the treatment of mitochondrial diseases. Muscle Nerve (2006) 1.19
Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations. Eur J Biochem (1999) 1.19
Mitochondrial diseases and the role of the yeast models. FEMS Yeast Res (2010) 1.16
Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. FASEB J (2011) 1.16
Intracellular distribution of the fluorescent dye nonyl acridine orange responds to the mitochondrial membrane potential: implications for assays of cardiolipin and mitochondrial mass. J Neurochem (2002) 1.14
Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev (2010) 1.14
Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chem Biol Interact (2006) 1.10
The mitochondrial tRNA(Leu)(UUR)) mutation in MELAS: a model for pathogenesis. Biochim Biophys Acta (1992) 1.08
Yeast models of human mitochondrial diseases. IUBMB Life (2003) 1.08
The yeast counterparts of human 'MELAS' mutations cause mitochondrial dysfunction that can be rescued by overexpression of the mitochondrial translation factor EF-Tu. EMBO Rep (2003) 1.07
New insights into the bioenergetics of mitochondrial disorders using intracellular ATP reporters. Mol Biol Cell (2003) 1.02
Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord (2009) 1.01
Skeletal muscle gene expression profiling in mitochondrial disorders. FASEB J (2005) 0.98
Cell and animal models of mtDNA biology: progress and prospects. Am J Physiol Cell Physiol (2006) 0.96
Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function. Diabetologia (2006) 0.96
Distinct nuclear gene expression profiles in cells with mtDNA depletion and homoplasmic A3243G mutation. Mutat Res (2005) 0.95
Riboflavin therapy. Biochemical heterogeneity in two adult lipid storage myopathies. Brain (1999) 0.93
Nutritional cofactor treatment in mitochondrial disorders. J Am Diet Assoc (2003) 0.93
Respiratory-deficient human fibroblasts exhibiting defective mitochondrial DNA replication. Biochem J (1995) 0.92
Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Pharmacotherapy (2010) 0.90
A colony color method identifies the vulnerability of mitochondria to oxidative damage. Mutagenesis (2002) 0.88
Yeast as a model of human mitochondrial tRNA base substitutions: investigation of the molecular basis of respiratory defects. RNA (2007) 0.87
Biogenesis of flavoprotein and cytochrome components in hepatic mitochondria from riboflavin-deficient rats. Biochem Biophys Res Commun (1978) 0.87
Applications of yeast in drug discovery. Prog Drug Res (2001) 0.85
Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology (1993) 0.85
Treatment of mitochondrial cytopathies. Semin Neurol (2001) 0.84
Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine. Proc Nutr Soc (1999) 0.84
Antioxidant and prooxidant activities of B group vitamins in lipid peroxidation. J UOEH (2006) 0.80
The use of individual patient's fibroblasts in the search for personalized treatment of nuclear encoded OXPHOS diseases. Mol Genet Metab (2011) 0.80
Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion. J Surg Res (2002) 0.80
Prooxidant effects of antioxidant vitamins. Introduction. J Nutr (1996) 0.79
Fluidizing effect of endogenous ubiquinone in bovine heart mitochondrial membranes. FEBS Lett (1984) 0.77
A practical approach to the diagnosis and management of MELAS: case report and review. Neurologist (2002) 0.77
MELAS: a mitochondrial encephalomyopathy syndrome. J Neurosci Nurs (1995) 0.76
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol (2007) 8.05
Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol (2008) 7.18
Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science (2013) 2.24
Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One (2010) 2.15
Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer (2009) 2.12
Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation. J Neurol Sci (2006) 1.95
Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer (2006) 1.71
Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis. Hum Mol Genet (2007) 1.67
Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy (2009) 1.65
Dlx-dependent and -independent regulation of olfactory bulb interneuron differentiation. J Neurosci (2007) 1.63
Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex. Neuron (2010) 1.55
Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer (2011) 1.54
Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Nutrition (2012) 1.46
Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency. FASEB J (2008) 1.41
The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. Eur J Cancer (2009) 1.39
Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer (2008) 1.35
Mitochondrial cytopathies. J Neurol (2003) 1.28
Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease. Arthritis Res Ther (2010) 1.18
Haploinsufficiency of COQ4 causes coenzyme Q10 deficiency. J Med Genet (2012) 1.16
Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. FASEB J (2011) 1.16
Life tables for world-wide comparison of relative survival for cancer (CONCORD study). Tumori (2008) 1.11
Lifespan decrease in a Caenorhabditis elegans mutant lacking TRX-1, a thioredoxin expressed in ASJ sensory neurons. FEBS Lett (2005) 1.11
NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun (2014) 1.09
Demethoxy-Q, an intermediate of coenzyme Q biosynthesis, fails to support respiration in Saccharomyces cerevisiae and lacks antioxidant activity. J Biol Chem (2004) 1.09
Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNA(Ile) mutation causing hypertrophic cardiomyopathy. Hum Mol Genet (2011) 1.09
Permissive corridor and diffusible gradients direct medial ganglionic eminence cell migration to the neocortex. Proc Natl Acad Sci U S A (2003) 1.08
Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes. Clin Biochem (2008) 1.07
The way to determine coenzyme Q. J Am Coll Cardiol (2013) 1.07
Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal (2013) 1.04
Chemotherapy induces an increase in coenzyme Q10 levels in cancer cell lines. Free Radic Biol Med (2005) 1.04
Cancer prevalence estimates in Italy from 1970 to 2010. Tumori (2007) 1.01
Light affects mitochondria to cause apoptosis to cultured cells: possible relevance to ganglion cell death in certain optic neuropathies. J Neurochem (2008) 0.98
Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations. EMBO Mol Med (2014) 0.98
N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes. Chem Biol Interact (2009) 0.96
The role of ubiquinone in Caenorhabditis elegans longevity. Ageing Res Rev (2004) 0.96
Complex I-associated hydrogen peroxide production is decreased and electron transport chain enzyme activities are altered in n-3 enriched fat-1 mice. PLoS One (2010) 0.96
Grafting of GABAergic precursors rescues deficits in hippocampal inhibition. Epilepsia (2010) 0.96
Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS One (2011) 0.95
Regional estimates of breast cancer burden in Italy. Tumori (2007) 0.95
Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q₁₀ effect on clinical improvement. PLoS One (2012) 0.93
Specificity of coenzyme Q10 for a balanced function of respiratory chain and endogenous ubiquinone biosynthesis in human cells. Biochim Biophys Acta (2005) 0.92
The apoptotic microtubule network preserves plasma membrane integrity during the execution phase of apoptosis. Apoptosis (2007) 0.92
Silencing of ubiquinone biosynthesis genes extends life span in Caenorhabditis elegans. FASEB J (2003) 0.91
The isolated carboxy-terminal domain of human mitochondrial leucyl-tRNA synthetase rescues the pathological phenotype of mitochondrial tRNA mutations in human cells. EMBO Mol Med (2014) 0.91
Coenzyme Q distribution in HL-60 human cells depends on the endomembrane system. Biochim Biophys Acta (2005) 0.91
Survival of European patients with central nervous system tumors. Int J Cancer (2011) 0.91
Regional estimates of stomach cancer burden in Italy. Tumori (2007) 0.90
Enhanced anti-oxidant protection of liver membranes in long-lived rats fed on a coenzyme Q10-supplemented diet. Exp Gerontol (2005) 0.90
NQR1 controls lifespan by regulating the promotion of respiratory metabolism in yeast. Aging Cell (2009) 0.90
Cell survival from chemotherapy depends on NF-kappaB transcriptional up-regulation of coenzyme Q biosynthesis. PLoS One (2009) 0.89
Coenzyme Q supports distinct developmental processes in Caenorhabditis elegans. Mech Ageing Dev (2008) 0.89
Is coenzyme Q a key factor in aging? Mech Ageing Dev (2010) 0.88
Respiratory-induced coenzyme Q biosynthesis is regulated by a phosphorylation cycle of Cat5p/Coq7p. Biochem J (2011) 0.88
Modifications of plasma proteome in long-lived rats fed on a coenzyme Q10-supplemented diet. Exp Gerontol (2007) 0.88
The influence of dietary lipid composition on liver mitochondria from mice following 1 month of calorie restriction. Biosci Rep (2012) 0.88
Aminoacyl-tRNA synthetases are multivalent suppressors of defects due to human equivalent mutations in yeast mt tRNA genes. Biochim Biophys Acta (2010) 0.88
Reactive oxygen species mediate the down-regulation of mitochondrial transcripts and proteins by tumour necrosis factor-alpha in L929 cells. Biochem J (2003) 0.88
Efficient differentiation of human embryonic stem cells into functional cerebellar-like cells. Stem Cells Dev (2010) 0.88
Diets based on virgin olive oil or fish oil but not on sunflower oil prevent age-related alveolar bone resorption by mitochondrial-related mechanisms. PLoS One (2013) 0.88
Cell fusion contributes to pericyte formation after stroke. J Cereb Blood Flow Metab (2008) 0.87
The influence of dietary lipid composition on skeletal muscle mitochondria from mice following 1 month of calorie restriction. J Gerontol A Biol Sci Med Sci (2012) 0.87
Yeast as a model of human mitochondrial tRNA base substitutions: investigation of the molecular basis of respiratory defects. RNA (2007) 0.87
Hydrogen peroxide- and cell-density-regulated expression of NADH-cytochrome b5 reductase in HeLa cells. J Bioenerg Biomembr (2003) 0.87
Clinical, biochemical and molecular aspects of cerebellar ataxia and Coenzyme Q10 deficiency. Cerebellum (2007) 0.87
Inorganic pyrophosphatase defects lead to cell cycle arrest and autophagic cell death through NAD+ depletion in fermenting yeast. J Biol Chem (2013) 0.87
Comparing cancer care, outcomes, and costs across health systems: charting the course. J Natl Cancer Inst Monogr (2013) 0.86
Can yeast be used to study mitochondrial diseases? Biolistic tRNA mutants for the analysis of mechanisms and suppressors. Mitochondrion (2009) 0.86
Effect of neuronal precursor cells derived from medial ganglionic eminence in an acute epileptic seizure model. Epilepsia (2010) 0.86
Recovery of MERRF fibroblasts and cybrids pathophysiology by coenzyme Q10. Neurotherapeutics (2012) 0.86
Coenzyme Q and the regulation of intracellular steady-state levels of superoxide in HL-60 cells. Biofactors (2005) 0.86
Apoptotic microtubule network organization and maintenance depend on high cellular ATP levels and energized mitochondria. Apoptosis (2011) 0.85
Methodology for estimation of cancer incidence, survival and prevalence in Italian regions. Tumori (2007) 0.85